{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:14:01Z","timestamp":1773278041525,"version":"3.50.1"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":806,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with pituitary tumours, ensuing hormonal abnormalities and mass effects are usually followed in multidisciplinary pituitary clinics and can represent a management challenge even during the times of non-pandemic. The COVID-19 pandemic has put on hold routine medical care for hundreds of millions of patients around the globe, while many pituitary patients' evaluations cannot be delayed for too long. Furthermore, the majority of patients with pituitary tumours have co-morbidities potentially impacting the course and management of COVID-19 (e.g. hypopituitarism, diabetes mellitus, hypertension, obesity and cardiovascular disease). Here, we summarize some of the diagnostic and management dilemmas encountered, and provide guidance on safe and as effective as possible delivery of care in the COVID-19 era. We also attempt to address how pituitary services should be remodelled in the event of similar crises, while maintaining or even improving patient outcomes. Regular review of these recommendations and further adjustments are needed, depending on the evolution of the COVID-19 pandemic status. We consider that the utilization of successful models of pituitary multidisciplinary care implemented during the COVID-19 pandemic should continue after the crisis is over by using the valuable and exceptional experience gained during these challenging times.<\/jats:p>","DOI":"10.1530\/eje-20-0473","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T15:27:12Z","timestamp":1588692432000},"page":"G17-G23","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":30,"title":["Endocrinology in the time of COVID-19: Management of pituitary tumours"],"prefix":"10.1093","volume":"183","author":[{"given":"Maria","family":"Fleseriu","sequence":"first","affiliation":[{"name":"Departments of Medicine (Endocrinology) and Neurological Surgery and Pituitary Center, Oregon Health & Science University , Portland, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1333-7580","authenticated-orcid":false,"given":"Olaf M","family":"Dekkers","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Leiden University Medical Centre , Leiden, The Netherlands"},{"name":"Department of Endocrinology, Leiden University Medical Centre , Leiden, The Netherlands"},{"name":"Department of Clinical Epidemiology, Aarhus University Hospital , Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4696-0643","authenticated-orcid":false,"given":"Niki","family":"Karavitaki","sequence":"additional","affiliation":[{"name":"Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham , Birmingham, UK"},{"name":"Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners , Birmingham, UK"},{"name":"Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust , Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"key":"2023021912093200100_","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11102-017-0838-2","article-title":"Criteria for the definition of Pituitary Tumour Centres of Excellence (PTCOE): a Pituitary Society Statement","volume":"20","author":"Casanueva","year":"2017","journal-title":"Pituitary"},{"key":"2023021912093200100_","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing's syndrome: a cohort study.","volume":"98","author":"Dekkers","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023021912093200100_","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"2023021912093200100_","article-title":"Endocrinology in the time of COVID-19: management of adrenal insufficiency","volume":"183","author":"Arlt","year":"2020","journal-title":"European Journal of Endocrinology"},{"key":"2023021912093200100_","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1210\/er.2015-1042","article-title":"Pituitary apoplexy","volume":"36","author":"Briet","year":"2015","journal-title":"Endocrine Reviews"},{"key":"2023021912093200100_","doi-asserted-by":"crossref","first-page":"R179","DOI":"10.1530\/EJE-14-0794","article-title":"Management of endocrine disease: pituitary tumour apoplexy","volume":"172","author":"Capatina","year":"2015","journal-title":"European Journal of Endocrinology"},{"key":"2023021912093200100_","doi-asserted-by":"crossref","first-page":"G9","DOI":"10.1530\/EJE-20-0338","article-title":"Endocrinology in the time of COVID-19: management of hyponatraemia and diabetes insipidus","volume":"183","author":"Christ-Crain","year":"2020","journal-title":"European Journal of Endocrinology"},{"key":"2023021912093200100_","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJMra1810772","article-title":"Pituitary-tumour endocrinopathies","volume":"382","author":"Melmed","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"2023021912093200100_","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023021912093200100_","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1530\/EJE-19-0349","article-title":"MANAGEMENT of ENDOCRINE DISEASE: Visual morbidity in patients with pituitary adenoma","volume":"181","author":"Lithgow","year":"2019","journal-title":"European Journal of Endocrinology"},{"key":"2023021912093200100_","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-20-0352","article-title":"Endocrinology in the time of COVID-19: management of Cushing's syndrome","volume":"183","author":"Newell-Price","year":"2020","journal-title":"European Journal of Endocrinology"},{"key":"2023021912093200100_","article-title":"Letter: Precautions for endoscopic transnasal skull base surgery during the COVID-19 pandemic","author":"Patel","year":"2020 125","journal-title":"Neurosurgery"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/183\/1\/EJE-20-0473.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/183\/1\/G17\/49174821\/eje-20-0473.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/183\/1\/G17\/49174821\/eje-20-0473.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T18:25:29Z","timestamp":1696098329000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/183\/1\/G17\/6653729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1530\/eje-20-0473","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7]]},"published":{"date-parts":[[2020,7,1]]}}}